Patent · US Active

4-phenoxy-nicotinamide or 4-phenoxy-pyrimidine-5-carboxamide compounds

US8729091B2 · kind B2 · utility

8Cited by

2References

12Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Caterina Bissantz · Rixheim, FR
Henrietta Dehmlow · Weil am Rhein, DE
Shawn David Erickson · Leonia, US
Kyungjin Kim · Livingston, US
Rainer E. Martin · Basel, CH
Ulrike Obst Sander · Sursee, CH
Sherrie Lynn Pietranico-Cole · Nutley, US
Hans Richter · Weil am Rhein, DE
Christoph Ullmer · Fischingen, DE

Key dates

Filing date	Feb 15, 2013
Grant date	May 20, 2014
Priority date	—
Expiry date	Feb 15, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to novel phenyl amide or pyridyl amide derivatives of the formulawherein A1, A2, B1, B2 and R1 to R11 are as defined in the description and in the claims, as well as pharmaceutically acceptable salts thereof. These compounds are GPBAR1 agonists and can be used as medicaments for the treatment of diseases such as type II diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.